AXIS Completes Previously Announced Transaction With Enstar
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 24 2025
0mins
Should l Buy AXS?
Source: Newsfilter
AXIS Capital and Enstar Transaction: AXIS Capital Holdings Limited and Enstar Group Limited have completed a loss portfolio transfer transaction, covering $3.1 billion in reinsurance segment reserves primarily related to casualty portfolios from 2021 and earlier years.
Transaction Details: The agreement involves a 75% ground-up quota share, with AXIS retroceding $2.3 billion of reserves to Enstar, facilitated by Enstar's subsidiary, Cavello Bay Reinsurance Limited, following regulatory approvals.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy AXS?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on AXS
Wall Street analysts forecast AXS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for AXS is 120.14 USD with a low forecast of 110.00 USD and a high forecast of 133.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
7 Analyst Rating
5 Buy
2 Hold
0 Sell
Moderate Buy
Current: 106.590
Low
110.00
Averages
120.14
High
133.00
Current: 106.590
Low
110.00
Averages
120.14
High
133.00
About AXS
AXIS Capital Holdings Limited is a holding company. The Company, through its operating subsidiaries, is a global specialty underwriter and provider of insurance and reinsurance solutions with operations in Bermuda, the United States, Europe, Singapore, and Canada. Its underwriting operations are organized around its global underwriting platforms: AXIS Insurance and AXIS Re. It operates through two segments: insurance and reinsurance. The insurance segment offers specialty insurance products to a variety of niche markets on a worldwide basis. The product lines in this segment are professional lines, property, liability, cyber, marine and aviation, accident and health, and credit and political risk. The reinsurance segment provides treaty reinsurance to insurance companies on a worldwide basis. The product lines in this segment are liability, accident and health, professional lines, credit and surety, motor, agriculture, marine and aviation, catastrophe, property, and engineering.
About the author

Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
- Book Value Growth: AXIS Capital reported an 18% increase in diluted book value per share to $77.20 in Q4 2025, reflecting a strong momentum over 13 consecutive quarters, which enhances investor confidence in the company's financial health.
- Record Premiums: The insurance segment achieved record gross written premiums of $7.2 billion, a 9% year-over-year increase, with new premiums written at $2.4 billion and underwriting income rising 40% to $597 million, indicating robust market competitiveness.
- Strategic Investment Impact: The company’s strategic investments in emerging markets and product expansion have driven profitable growth, with enhanced operational efficiency expected from the integration of new AI technologies, which will further optimize business processes and customer experience.
- Optimistic Outlook: Management expressed confidence in achieving mid- to high single-digit premium growth for 2026, despite potential challenges in the reinsurance market, while maintaining a focus on cost management and profitability to ensure continued shareholder returns.
See More
- Earnings Announcement Schedule: Axis Capital Holdings is set to release its Q4 2023 earnings on January 28 after market close, with consensus EPS estimate at $3.12, reflecting a 5.1% year-over-year increase, while revenue is projected at $1.33 billion, down 9.5% year-over-year.
- Historical Performance Review: Over the past two years, Axis Capital has surpassed EPS estimates 88% of the time and revenue estimates 50% of the time, indicating a solid track record in maintaining profitability.
- Expectation Adjustment Dynamics: In the last three months, EPS estimates have seen 8 upward revisions and 1 downward revision, while revenue estimates have had 1 upward revision with no downward adjustments, suggesting increased market confidence in the company's future performance.
- Analyst Rating Changes: Despite a recent downgrade from BofA Securities citing challenges in pricing trends, the company still demonstrates potential for double-digit insurance growth in 2026 through new initiatives and its partnership with RAC Re.
See More
- Earnings Release Schedule: AXIS Capital is set to announce its Q4 2025 financial results on January 28, 2026, after market close, demonstrating the company's commitment to transparency and investor communication.
- Investor Teleconference: The company will host a teleconference on January 29, 2026, at 8:30 AM ET, where CEO Vince Tizzio and CFO Peter Vogt will discuss the earnings report and related matters, enhancing engagement with investors.
- Financial Strength Overview: As of September 30, 2025, AXIS Capital reported shareholders' equity of $6.4 billion, reflecting a robust financial foundation in the insurance and reinsurance sectors, which helps attract investor confidence.
- Rating Information: AXIS Capital's operating subsidiaries have received an
See More
- Rating Downgrade: Bank of America Securities downgraded AXIS Capital's rating from Buy to Neutral and cut the price target from $116 to $115, indicating potential challenges in pricing trends over the next two years, which may affect investor confidence.
- Earnings Forecast Reduction: The analyst noted that AXIS Capital's earnings estimates for 2026 and 2027 are below consensus due to rising acquisition costs and less favorable reserve development, which could limit the company's future profitability.
- Decreased Underwriting Transparency: As managing general agent (MGA) risks and contract-binding business increase in proportion to underwriting, AXIS's underwriting transparency is expected to decline, potentially impacting investor confidence in the company's risk management capabilities.
- Stock Price Volatility: At the time of publication, AXIS Capital's shares fell by 3.1% to $102.24, reflecting the market's negative reaction to the downgrade, which may affect the company's short-term market performance.
See More
- Poor ROE Performance: Accsys Technologies reports a Return on Equity (ROE) of 3.4%, significantly below the industry average of 5.0%, indicating substantial inefficiencies in utilizing investor capital, which may lead to diminished investor confidence.
- Declining Profit Trend: The company has experienced a 30% decline in net income over the past five years, closely tied to its low ROE, reflecting challenges in profitability and capital allocation that could impact future investment appeal.
- Reinvestment Efficiency Issues: Although Accsys does not pay regular dividends, implying all profits are reinvested, the low ROE suggests these reinvestments have not effectively driven profit growth, raising concerns about its future growth potential among investors.
- Analyst Expectations for Improvement: Despite the current underperformance, analysts predict a significant improvement in Accsys Technologies' earnings growth rate, which could support a rebound in stock prices, prompting investors to monitor changes in related forecasts.
See More
- Quarterly Dividend Announcement: AXIS Capital's Board of Directors has declared a quarterly dividend of $0.44 per common share, payable on January 15, 2026, which underscores the company's commitment to shareholder returns and enhances investor confidence.
- Preferred Share Dividend: Additionally, the Board declared a dividend of $34.375 per Series E 5.50% preferred share, equivalent to $0.34375 per depositary share, further increasing the company's attractiveness in the capital markets.
- Financial Health Status: As of September 30, 2025, AXIS Capital reported shareholders' equity of $6.4 billion, reflecting a solid financial foundation that supports future dividend payments.
- Rating Advantage: AXIS Capital's operating subsidiaries have received an
See More










